Iterum Therapeutics plc (ITRM) Fundamentals

Iterum Therapeutics PLC is a pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.
SHARE INFORMATION
Market Cap$ 40,539,441
Shares Outstanding183,353,418
Float180,890,994
Percent Float98.66%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.75
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions62
Institutional Holdings Date2022-05-31
Institutional Bought Previous 3 Months153,055
Institutional Holdings Percent3.3%
Institutional Sold Previous 3 Months303,492
Insider Holdings Date2022-05-31
Insider Bought Previous 3 Months409,953
Insider Holdings Percent0.6
Insider Sold Previous 3 Months443,608
Insider Shares Owned1,046,517
TRADING INFO
52 Week High$ 2.48
52 Week Low$ 0.18
52 Week High Change$ -90.75
21 Day Moving Average$ 0.2159
21 Day Extended Moving Average$ 0.215175
50 Day Moving Average$ 0.2347
50 Day Extended Moving Average$ 0.243377
200 Day Moving Average$ 0.398193
200 Day Extended Moving Average$ 0.460959
10 Day Average Volume1,594,989
20 Day Average Volume1,311,176
30 Day Average Volume1,159,039
50 Day Average Volume1,144,570
Alpha-0.034752
Beta1.2016
Standard Deviation0.314601
R20.038940
7 Day Price Change$ 0.0212
7 Day Percent Change10.61%
21 Day Price Change$ -0.0149
21 Day Percent Change-6.31%
30 Day Price Change$ -0.0023
30 Day Percent Change-1.03%
Month to Date Price Change$ -0.0089
Month to Date Percent Change-3.87%
Quarter to Date Price Change$ -0.1339
Quarter to Date Percent Change-37.72%
180 Day Price Change$ -0.1889
180 Day Percent Change-46.07%
200 Day Price Change$ -0.263
200 Day Percent Change-54.33%
Year to Date Price Change$ -0.1707
Year to Date Percent Change-43.57%

Iterum Therapeutics plc (ITRM) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.50
Int Coverage2.40
Current Ratio7.60
Leverage Ratio1.90
Quick Ratio7.50
Long Term Debt To Capital0.31
VALUATION MEASURES
PE Ratio4.90
Enterprise Value$ -17,406,084
Price to Sales0.00
Price to Free Cash-2.00
PE High Last 5 Years0.00
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets3.87
Return on Equity9.62
Return on Capital9.78

Iterum Therapeutics plc (ITRM) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG
CEOCorey N. Fishman
Emplyoees13
Last AuditUQ
CIK0001659323
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
AddressFitzwilliam Court, 1st Floor
Leeson Close
Dublin, 2
Websitehttps://www.iterumtx.com
Facsimile-
Telephone+353 16694820
EmailIR@iterumtx.com
Your Recent History
NASDAQ
ITRM
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220703 11:16:00